Zimmer Biomet Holdings Share Buybacks increased by 0.0% to $250.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.8%, from $229.80M to $250.10M. Over 3 years (FY 2022 to FY 2025), Share Buybacks shows an upward trend with a 56.8% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.60M | $31.60M | $31.60M | $31.60M | $267.60M | $14.30M | $0.00 | $410.30M | $113.60M | $85.90M | $596.30M | $72.20M | $229.80M | $7.20M | $0.00 | $250.00M | $250.10M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +746.8% | -94.7% | -100.0% | — | -72.3% | -24.4% | +594.2% | -87.9% | +218.3% | -96.9% | -100.0% | — | +0.0% |
| YoY Change | — | — | — | — | +746.8% | -54.7% | -100.0% | >999% | -57.5% | +500.7% | — | -82.4% | +102.3% | -91.6% | -100.0% | +246.3% | +8.8% |